![Silvano Spinelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Silvano Spinelli
Oprichter bij
BiovelocITA Srl
Profiel
Mr. Silvano Spinelli is a Venture Partner at Sofinnova Partners SAS, a Chairman at Enthera Srl, a Chairman at BiovelocITA Srl, a Chairman at Alia Therapeutics Srl and a Chairman at Nephris Srl.
Mr. Spinelli was previously employed as a Chairman & Chief Executive Officer by EOS SpA, a Chief Executive Officer by Novuspharma SpA, and a Managing Director by Cell Therapeutics, Inc. He received his undergraduate degree from the University of Pisa.
Actieve functies van Silvano Spinelli
| Bedrijven | Functie | Begin |
|---|---|---|
BiovelocITA Srl
 BiovelocITA Srl Investment ManagersFinance Biovelocita invests in startups located in Italy. The firm focuses on the biotech sector. It provide financing for early stage capital requirements. | Oprichter | 01-01-2015 |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 12-03-2018 |
Nephris Srl
 Nephris Srl Miscellaneous Commercial ServicesCommercial Services Develops therapies for chronic kidney disease in patients with diabetes | Voorzitter | - |
Alia Therapeutics Srl
 Alia Therapeutics Srl BiotechnologyHealth Technology Develops treatment of genetic diseases with genomic editing technology | Voorzitter | - |
Enthera Srl
 Enthera Srl BiotechnologyHealth Technology Operates as a biotech manufacturing company that develops biotherapeutics treatments for underserved auto-immune disorders | Oprichter | 01-01-2016 |
Eerdere bekende functies van Silvano Spinelli
| Bedrijven | Functie | Einde |
|---|---|---|
Novuspharma SpA
 Novuspharma SpA Pharmaceuticals: MajorHealth Technology Researches treatments for cancer and develops pharmaceuticals related to cancer treatments | Oprichter | 27-07-2011 |
| CTI BIOPHARMA CORP. | Corporate Officer/Principal | 19-08-2005 |
EOS SpA
 EOS SpA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Algemeen Directeur | - |
Opleiding van Silvano Spinelli
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
70
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Novuspharma SpA
Novuspharma SpA Pharmaceuticals: MajorHealth Technology Researches treatments for cancer and develops pharmaceuticals related to cancer treatments | Health Technology |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners invests in companies located in the United States, France and Europe. The firm targets companies operating in the fields of life sciences and technology sectors. It provides financing for seed and early stage capital requirements. | Finance |
University of Pisa
 University of Pisa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EOS SpA
EOS SpA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
BiovelocITA Srl
BiovelocITA Srl Investment ManagersFinance Biovelocita invests in startups located in Italy. The firm focuses on the biotech sector. It provide financing for early stage capital requirements. | Finance |
Enthera Srl
Enthera Srl BiotechnologyHealth Technology Operates as a biotech manufacturing company that develops biotherapeutics treatments for underserved auto-immune disorders | Health Technology |
Alia Therapeutics Srl
Alia Therapeutics Srl BiotechnologyHealth Technology Develops treatment of genetic diseases with genomic editing technology | Health Technology |
Nephris Srl
Nephris Srl Miscellaneous Commercial ServicesCommercial Services Develops therapies for chronic kidney disease in patients with diabetes | Commercial Services |
